fanter®
farmaceutica paraguaya s.a. paraguay - dapagliflozina 10,000 mg - comprimidos recubiertos - cada comprimido recubierto contiene: dapagliflozina 10,000 mg
forxiga® 5 mg
astrazeneca pharmaceutical lp - dapagliflozina (eq. a 6,15 mg de propanediol de dapagliflozina) - comprimido recubierto - 5 mg
forxiga® 10 mg
astrazeneca pharmaceutical lp - dapagliflozina (eq. a 12,3 mg de propanediol de dapagliflozina) - comprimido recubierto - 10 mg
dapaone 5 5 mg tableta recubierta
msn labs peru s.a.c. - droguerÍa - tableta recubierta - por tableta - - dapagliflozina
dapaone 10 10 mg tableta recubierta
msn labs peru s.a.c. - droguerÍa - tableta recubierta - por tableta - - dapagliflozina
glixafor 10 10 mg tableta recubierta
seven pharma s.a.c. - droguerÍa - tableta recubierta - por tableta - - dapagliflozina
glixafor 5 5mg tableta recubierta
seven pharma s.a.c. - droguerÍa - tableta recubierta - por tableta - - dapagliflozina
edistride
astrazeneca ab - dapagliflozin propanediol monohidrato - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogas usadas en diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. además de otros productos medicinales para el tratamiento de la diabetes tipo 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 y 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - dapagliflozin propanediol monohidrato - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogas usadas en diabetes - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. además de otros productos medicinales para el tratamiento de la diabetes tipo 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 y 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
forxiga 10 mg comprimido recubierto
astrazeneca (distribución exclusiva por gramón bagó de uruguay s.a) - comprimido recubierto - dapagliflozina 10 mg comprimido